Acute progression of aspergillosis in a patient with lung cancer receiving nivolumab

39Citations
Citations of this article
35Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A 65-year-old man with chronic progressive pulmonary aspergillosis (CPPA) was admitted for the treatment of lung adenocarcinoma while receiving an immune checkpoint inhibitor, nivolumab. The tumour responded well to the therapy, but the cavity of CPPA became large in contrast to the tumour after 20 courses of therapy. He was diagnosed as having exacerbation of CPPA and successfully and concurrently treated with an antifungal agent and nivolumab. Since there was absence of obvious immunosuppression and the presence of a drastic effect on tumour remission during nivolumab therapy, this phenomenon suggested that the trigger of CPPA progression was dependent not on immunosuppression but on a hyperreaction to microorganisms, which was similar to the immune recon-stitution inflammatory syndrome caused by nivolumab. This was a thought-provoking case in which the immune checkpoint inhibitor had a paradoxical effect for the tumour and infection.

References Powered by Scopus

The spectrum of serious infections among patients receiving immune checkpoint blockade for the treatment of melanoma

240Citations
N/AReaders
Get full text

Anti-PD1 Antibody Treatment and the Development of Acute Pulmonary Tuberculosis

125Citations
N/AReaders
Get full text

Opportunistic infections in patients treated with immunotherapy for cancer

101Citations
N/AReaders
Get full text

Cited by Powered by Scopus

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Immune checkpoint inhibitors, cell adhesion inhibitors, sphingosine-1-phosphate receptor modulators and proteasome inhibitors)

104Citations
N/AReaders
Get full text

Invasive Pulmonary Aspergillosis

78Citations
N/AReaders
Get full text

Clinical diagnosis and treatment of immune checkpoint inhibitor-associated pneumonitis

67Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Uchida, N., Fujita, K., Nakatani, K., & Mio, T. (2018). Acute progression of aspergillosis in a patient with lung cancer receiving nivolumab. Respirology Case Reports, 6(2). https://doi.org/10.1002/rcr2.289

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 7

39%

Researcher 7

39%

Professor / Associate Prof. 3

17%

Lecturer / Post doc 1

6%

Readers' Discipline

Tooltip

Medicine and Dentistry 13

72%

Biochemistry, Genetics and Molecular Bi... 3

17%

Computer Science 1

6%

Nursing and Health Professions 1

6%

Save time finding and organizing research with Mendeley

Sign up for free